Stephen Shafran - Concepedia

Author

Stephen Shafran

Also Known As

S D Shafran, S Shafran, S. D Shafran, S. D. Shafran, S. Shafran, S.D. Shafran, SD Shafran, Stephen D Shafran, Stephen Shafran

Publications

413

Citations

H-Index

Concepts

All Affiliations

University of Alberta Casa Sollievo della Sofferenza Gilead Sciences (United States)University of British Columbia

About

Stephen Shafran is an author at University of Alberta specializing in medicine, hepatitis, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	301
2	Public Health	1	1	12
3	Epidemiology	1	1	12
4	Global Health	1	1	12
5	Hepatology	1	1	12

Stephen Shafran

Publications

397

Citations

H-Index

Page 1

	Year	Citations
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients Peter Phillips, Stephen Shafran, Gary Garber, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentNon-neutropenic PatientsAntifungal AgentsPharmacologyClinical Mycology	1997	220
Long-Term Persistence of HCV NS5A Resistance-Associated Substitutions after Treatment with the HCV NS5A Inhibitor, Ledipasvir, without Sofosbuvir David Wyles, Alessandra Mangia, Wendy Cheng, Antiviral Therapy	2017	72
P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trial Paul Y. Kwo, E. Gane, Cheng‐Yuan Peng, Journal of Hepatology Viral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirology	2015	38
Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir Jill Hall, Christine Hughes, Michelle Foisy, International Journal of STD & AIDS Drug InteractionsCytochrome P450 3A4UrologyPharmacologyImmunology	2013	31
Treatment of acute uncomplicated urinary tract infections with 3 days of lomefloxacin compared with treatment with 3 days of norfloxacin Lindsay E. Nicolle, Jacques Dubois, Alain Martel, Antimicrobial Agents and Chemotherapy	1993	24
GS-03-Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts Alessandra Mangia, Scott Milligan, Mandana Khalili, Journal of Hepatology HepatologyHepatitis CViral HepatitisGlobal HealthHepatitis B	2019	12

Page 1